2015-11-16 20:26:15 UTC

Current Role of FMT for Treatment of C. Difficile

Duration

25 minutes

Takeaways

Christina M. Surawicz, MD, MACG, discusses the efficacy of fecal microbiota transplantation to treat C. difficile, IBD and other GI disorders.

Presented at Digestive Disease Week®, May 16-19, 2015, Walter E. Washington Convention Center, Washington, DC

About the Instructors

Dr. Christina M. Surawicz, MD, MACG
Professor of Medicine, Division of Gastroenterology
University of Washington School of Medicine

This is only a preview. Full access is reserved for AGA members. Login or learn more about becoming a member.

Login

More on Fecal microbiota transplant

2018 AGA Postgraduate Course

June 2, 2018

Secure your spot for this clinically focused, multi-topic course that offers immediately applicable information. Held in conjunction with DDW®. Save $75 when you register by April 18.

AGA’s Fecal Microbiota Transplantation (FMT) National Registry Enrolls 1st Patient

Jan. 10, 2018

The registry, which promises to be the largest FMT study, also announces collaborations with American Gut and OpenBiome.

Largest Planned Fecal Microbiota Transplantation (FMT) Study Enrolls 1st Patient

Jan. 10, 2018

The AGA FMT National Registry also announces collaborations with American Gut and OpenBiome.